Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Qingdao Norson Biotechnology

Request full access

Functional probiotics manufacturer for food and health industries

ChinaFounded 2018

About Qingdao Norson Biotechnology

Qingdao Norson Biotechnology Co., Ltd. is a high-tech enterprise established in 2018, focusing on the research, development, production, and sales of functional probiotic core raw materials. The company serves clients across the food, health food, precision medicine, and daily chemical products industries by providing probiotic powders, fermented food strains, and comprehensive application solutions. The business model operates as both a direct manufacturer and a contract manufacturing enterprise (OEM/ODM) for products like edible probiotic powders, solid drinks, and fermented lactic acid beverages.

The company was founded by Chairman Zhang Mingjun. Under his leadership, Qingdao Norson Biotechnology has achieved significant milestones, including being recognized as a "specialized, refined, and new" enterprise in Qingdao in August 2021 and securing a 40 million yuan equity investment from the Shandong Provincial Science and Technology Innovation New Kinetic Energy Venture Capital Fund in March 2020. The company's facilities include over 8,000-9,000 square meters of standardized workshops, with nearly 2,000 square meters of GMP-compliant clean workshops. This infrastructure supports an annual production capacity of over 30 tons of probiotic powder and 6,000 tons of beverages.

Norson Biotechnology controls the entire industrial chain from strain isolation and cultivation to freeze-drying and production. The company possesses a strain bank of over 2,000 strains, with more than 100 available for industrial production. It has also established the "Qingdao Lactic Acid Bacteria Engineering Research Center" to advance technological innovation. Its client base includes notable companies in the beverage and food sectors, such as Mixue Bingcheng Co., Ltd. and Nayuki Holdings Limited. The firm markets its products globally, with a presence in North America, South America, Europe, Asia, Africa, and Oceania.

Source: Dealroom company data

Qingdao Norson Biotechnology in its local ecosystem

Live from Dealroom

The Qingdao Norson Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • OrbiMed
  • Sunshine Insurance Group Co
  • Kunlun Trust
  • Horus Capital
  • Detong Capital
  • Huajin Capital
Employees 1 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Qingdao Norson Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Qingdao Norson Biotechnology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.